0001214659-21-003636.txt : 20210330 0001214659-21-003636.hdr.sgml : 20210330 20210330174156 ACCESSION NUMBER: 0001214659-21-003636 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210326 FILED AS OF DATE: 20210330 DATE AS OF CHANGE: 20210330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sharp Shalini CENTRAL INDEX KEY: 0001377202 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 21788651 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-52136.xml PRIMARY DOCUMENT X0306 4 2021-03-26 0001576263 Mirati Therapeutics, Inc. MRTX 0001377202 Sharp Shalini C/O MIRATI THERAPEUTICS 9393 TOWN CENTRE DR. SUITE 200 SAN DIEGO CA 92121 true false false false Common Stock 2021-03-26 4 A false 2424 0.00 A 2424 D Non Qualified Stock Option (right to buy) 164.98 2021-03-26 4 A false 3523 0 A 2031-03-25 Common Stock 3523 3523 D Grant of Restricted Stock Units (RSUs). Shares will vest 1/3rd annually on the anniversary of the grant date. The shares subject to the Option vest and become exercisable in 36 equal monthly installments following the date of grant. /s/ Vickie Reed, Attorney-inFact 2021-03-30